임상 분리 균주의 항생제 감수성 유형

In vitro Evaluation of Antimicrobial Agents Susceptibility Against Several Clinical Isolates

In vitro activity of commonly used antimicrobial agents against several clinical isolates were studied. In the case of E. coli, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, cefazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 100<, 100, 25. 0.2. 100<. 3.13, and 12.5mcg/ml, respectively. In the case of Kl. Pneumoniae, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, cefazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 1O0<, 12.5, 100<, 0.1, 100<, 1.6, and 0.4mcg/ml, respectively. In the case of Enterobacter sp, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, cefazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 100<, 100<, 100<, 6.25, 1O0<, 100 and 1.57mcg/ml, respectively. In the case of A-cinetobacter sp, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, cefazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 100<, 1O0<, 100<, 100<, 1O0<, 100< and 50mcg/ml, respectively. In the case of Pseudomonas sp, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, cefazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 1O0<, 100<, 100<, 50, 1O0<, 25 and 25mcg/ml, respectively. In the case of S. aureus, the MICs at which 90% of the bacteria are inhibited of ampicillin, Unasyn, cefazoline, cefotaxim, carbenicillin, gentamicin and ofloxacin were 50, 50, 100<, 100<, 50, 50, and 100mcg/ml, respectively.